Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
06/2013
06/11/2013US8460678 Use of triplex structure DNA in transferring nucleotide sequences
06/11/2013CA2513388C Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
06/06/2013WO2013078786A1 Hepatitis b virus mutant, mutant amplification kit and use thereof
06/06/2013WO2013052832A3 Simian (gorilla) adenovirus or adenoviral vectors and methods of use
06/06/2013WO2013032942A9 Influenza viruses with mutant pb2 gene segment as live attenuated vaccines
06/06/2013US20130143303 Bionanomaterials and Their Synthesis
06/05/2013EP2598127A1 Anti-viral azide containing compounds
06/05/2013CN103140145A Dry storage stabilizing composition for biological materials
06/05/2013CN103131676A Silkworm recombinant baculovirus showing recombinant human tumor necrosis factor receptor-Fc fusion protein gene, and preparing method and application thereof
06/05/2013CN103130895A Specific binding members against synaptophysin
06/05/2013CN102766604B Swine influenza virus strain and application thereof
06/05/2013CN102337251B Chimaera for HK97 bacteriophage virus-like particle and application of chimaera
06/05/2013CN102286535B Method for transdifferentiation of fibroblasts into hepatic stem cells
06/05/2013CN102127525B Adaption method of influenza virus vaccine strains on Vero cells
06/05/2013CN101921733B Preparation method and application of Qbeta-2aa phage virus-like particle protein
06/05/2013CN101899419B Insect baculovirus expression system and method for expressing E2 protein using same
06/05/2013CN101267834B 白介素-1偶联物及其用途 Interleukin-1 conjugates and their use
06/04/2013US8455628 PP1 ligands
06/04/2013US8455246 Serum-free mammalian cell culture medium, and uses thereof
06/04/2013US8454974 Adaptive mutations allow establishment of JFH1-based cell culture systems for hepatitis C virus genotype 4A
06/04/2013US8454973 Modified human hepatitis C virus genomic RNA that can be autonomously replicated
06/04/2013US8454946 N-maleimidyl polymer derivatives
05/2013
05/30/2013WO2013076309A1 Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
05/30/2013CA2856455A1 Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
05/30/2013CA2856137A1 Virus vectors for highly efficient transgene delivery
05/29/2013EP2596862A2 Particle binding
05/29/2013EP2596099A1 Method for harvesting expression products
05/29/2013EP2596098A1 High yield yellow fever virus strain with increased propagation in cells
05/29/2013CN1813061B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
05/29/2013CN103124787A Method for producing virus vector
05/29/2013CN103122354A Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant
05/29/2013CN103122336A Goose parvovirus H-strain and application thereof in preventing and treating gosling plague
05/28/2013US8450087 Use of triplex structure DNA in transferring nucleotide sequences
05/28/2013CA2517258C Recombinant measles virus comprising dengue or west nile virus polynucleotides, and their use in vaccinal and therapeutic applications
05/28/2013CA2459769C Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
05/28/2013CA2406180C Viruses comprising mutant ion channel protein
05/23/2013WO2013073843A1 Novel isolated bacteriophage having e. coli-specific bactericidal activity and antibacterial composition comprising the same
05/23/2013US20130130355 Method and system of particle-phage epitope complex
05/23/2013US20130129683 Modified Rodent Parvovirus Capable of Propagating and Spreading Through Human Gliomas
05/23/2013US20130129614 Microorganisms for imaging and/or treatment of tumors
05/22/2013EP2593136A1 Live attenuated parvovirus
05/22/2013EP2593135A1 Modified viral strains, and method for improving the production of vaccine seeds of the influenza virus
05/22/2013CN103118704A Modified viral strains, and method for improving the production of vaccine seeds of the influenza virus
05/22/2013CN103114087A RNA(Ribonucleic Acid)and application thereof in diseases of cardiovascular system
05/22/2013CN102559754B Preparation method and application of EV71 type full length infectious clone with luciferase tag
05/22/2013CN102417912B Molecular design of porcine parvovirus-like particle B cell epitope insertion site
05/22/2013CN102352345B Preparation method of newcastle disease HI antigen
05/22/2013CN102205118B Biological product and preparation method thereof
05/22/2013CN102002482B Method for producing PRRS (Porcine Reproductive and Respiratory Syndrome) viruses
05/22/2013CN101688185B Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection
05/22/2013CN101189254B 疫苗 Vaccine
05/21/2013US8445745 Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection
05/21/2013CA2553805C Improved inactivated feline calicivirus vaccines
05/16/2013WO2013071233A1 Methods for detecting infectious agents and a novel virus detected thereby
05/16/2013WO2013068847A2 Compositions and methods for treatment of cytomegalovirus
05/16/2013WO2013068743A1 Novel bacteriophages
05/16/2013WO2013068593A1 Influenza virus -like particles (vlps) comprising hemagglutinin produced nicotiana tabacum
05/16/2013WO2013041877A3 Influenza virus mutant expressing a haemagglutinin protein without functional signal sequence for use as vaccine
05/16/2013WO2013027988A3 Recombinant adenovirus comprising trans-splicing ribozyme and cancer-treating gene, and use thereof
05/16/2013US20130122585 Synthetic gagpol genes and their uses
05/16/2013DE69132920C5 Methode zur Herstellung von filamentösen, antikörper-präsentierenden Bakteriophagenpartikeln durch Verwendung von Phagemiden und die daduch hergestellten Bakteriophagenpartikel Method for the production of filamentous bacteriophage particles by antibody-presenting use of phagemids and the bacteriophage produced Daduchus
05/16/2013CA2855252A1 Influenza virus -like particles (vlps) comprising hemagglutinin produced nicotiana tabacum
05/15/2013EP2591800A1 Herpes simplex virus combined subunit vaccines and methods of use thereof
05/15/2013EP2591097A1 Norovirus derived immunogenic compositions and methods
05/15/2013EP2591096A1 Process for removing adventitious agents during the production of a virus in cell culture
05/15/2013CN103103623A Adenovirus chip and application thereof
05/15/2013CN103103166A Plant stress tolerance associated protein TaNCED1, and coding gene and application thereof
05/15/2013CN103103164A Method for culturing recombinant avian influenza virus H5N1 subtype
05/15/2013CN103103163A Lentogenic CH60 strain of duck virual hepatitis virus and attenuated live vaccine thereof
05/15/2013CN103102409A Method for inactivating virus contained in trypsin inhibitor extracted from human urine
05/15/2013CN103100083A Vaccine and preparation method thereof
05/15/2013CN103100082A Method for preparing porcine circovirus type 2 inactivated vaccine by utilizing bioreactor
05/15/2013CN102399777B Recombinant plasmid and recombinant oncolytic virus prepared by using the same
05/15/2013CN102174481B Cotton leafworm genetically engineered virus I and construction method thereof
05/15/2013CN102174480B Prodenia litura genetically engineered virus NO.2 and construction method thereof
05/15/2013CN101920020B New application of human MED19 genes in tumor therapy
05/15/2013CN101768206B Method for purifying recombinant human serum albumin protein and application thereof
05/14/2013US8440447 Extraction and concentration method
05/14/2013US8440446 Bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus Enterococcus
05/10/2013WO2012171026A3 Methods for high yield virus production
05/10/2013WO2012169939A3 Recombinant dna elements for the expression of recombinant proteins in a host cell
05/09/2013US20130115692 Methods and compositions relating to improved lentiviral vectors and their applications
05/09/2013US20130115683 Method for the preparation of a pharmaceutical composition
05/09/2013US20130115592 Modified human hepatitis c virus genomic rna that can be autonomously replicated
05/09/2013US20130115242 Modified Viral Strains and Method for Improving the Production of Vaccine Seeds of Influenza Virus
05/09/2013US20130115235 Swine influenza hemagglutinin variants
05/08/2013EP2589602A2 Development of dengue virus vaccine components
05/08/2013EP2588596A2 Immortalized avian cell lines
05/08/2013CN103096906A Novel strains of bacteriophages for the treatment of bacterial infections, particularly by strains of drug-resistant bacteria of the genus stenotrophomonas
05/08/2013CN103088062A Construction of goat beta-lactoglobulin gene targeting plasmid based on adeno-associated virus and targeting method thereof
05/08/2013CN103088061A Application of RNA and carrier in preparation of product for preventing and/or treating liver cancer
05/08/2013CN103088049A DNA (Deoxyribose Nucleic Acid)-based infectious clone of a Japanese encephalitis virus SA14-14-2 strain, as well as construction method and application thereof
05/08/2013CN103088038A Flavivirus vaccine
05/08/2013CN103087997A Recombinant adeno-associated virus expressing BDNF-HA2TAT, and construction method thereof
05/08/2013CN103087996A Recombinant porcine reproductive and respiratory syndrome virus as well as preparation method and application thereof
05/08/2013CN103087995A Method of preparing foot-and-mouth disease vaccine by using BHK-21 adherent cells
05/08/2013CN103087994A Coxsackievirus A16-type virus strain and use thereof
05/08/2013CN103087993A Large-scale production method of porcine transmissible gastroenteritis virus
05/08/2013CN103087200A Pig IFN (interferon) gamma-Fc fusion protein as well as coding gene and expression method of pig IFN (interferon) gamma-Fc fusion protein
05/08/2013CN103087192A Anti-KDR antibodies and methods of use
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 267